Bearz A, Martini JF, Jassem J, Kim SW, et al. Efficacy of lorlatinib in treatment-naive patients with ALK-positive advanced non-small cell lung cancer in relation to EML4::ALK variant type and ALK with or without TP53 mutations. J Thorac Oncol 2023 Aug 2:S1556-0864(23)00691.
PMID: 37541389